OceansBio co.,ltd. (XKON:332190)

OceansBio co.,ltd. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	489.18	830.24
Cash & Short-Term Investments	489.18	830.24
Cash Growth	-41.08%	-
Other Receivables	1.15	25.5
Receivables	1.15	30.5
Prepaid Expenses	4	-
Other Current Assets	106.56	37.11
Total Current Assets	600.89	897.85
Property, Plant & Equipment	117.54	187.62
Other Intangible Assets	24.35	19.41
Other Long-Term Assets	118.21	113.21
Total Assets	860.97	1,218
Accrued Expenses	33.89	14.17
Short-Term Debt	10	10
Current Portion of Long-Term Debt	750	750
Current Unearned Revenue	51.33	-
Other Current Liabilities	21.87	-
Total Current Liabilities	867.09	774.17
Long-Term Debt	200	100
Other Long-Term Liabilities	79.73	57.94
Total Liabilities	1,211	954.01
Common Stock	147.78	147.78
Additional Paid-In Capital	1,564	1,170
Retained Earnings	-2,094	-1,080
Comprehensive Income & Other	0	-
Total Common Equity	-382.35	237.09
Shareholders' Equity	-349.9	264.08
Total Liabilities & Equity	860.97	1,218
Total Debt	960	860
Net Cash (Debt)	-470.82	-29.76
Net Cash Per Share	-318.68	-20.14
Filing Date Shares Outstanding	1.48	1.48
Total Common Shares Outstanding	1.48	1.48
Working Capital	-266.2	123.68
Book Value Per Share	-258.80	160.45
Tangible Book Value	-406.69	217.68
Tangible Book Value Per Share	-275.28	147.32
Machinery	213.3	193.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.